Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenkman Capital Management is an independent, research-driven investment management firm specializing in the leveraged finance markets. Founded in 1985 by Mark Shenkman, the firm focuses on high-yield bonds, leveraged loans, and other credit-related strategies for institutional and individual investors globally. While the firm invests across various sectors, including healthcare and life sciences, it is an asset management entity rather than a biotechnology or pharmaceutical developer. Shenkman is recognized for its disciplined investment process and deep expertise in credit analysis and risk management. The firm maintains a significant presence in the credit markets with offices in New York, Connecticut, and London.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenkman Capital Management.